scholarly article | Q13442814 |
P356 | DOI | 10.1185/030079907X242575 |
P698 | PubMed publication ID | 17971283 |
P2093 | author name string | Elke Hunsche | |
Jeroen P Jansen | |||
Ernest H Choy | |||
Paul Bacon | |||
James Pellissier | |||
Julian T Nash | |||
Andrew Ostor | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ankylosing spondylitis | Q52849 |
P304 | page(s) | 3069-3078 | |
P577 | publication date | 2007-12-01 | |
P1433 | published in | Current Medical Research and Opinion | Q5195063 |
P1476 | title | Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK. | |
P478 | volume | 23 |
Q36894945 | Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? |
Q34610283 | Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis |
Q36818355 | Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration |
Q24235971 | Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity |
Search more.